Skip to main content
James Chen, MD, Oncology, Columbus, OH

JamesLinChenMD

Oncology Columbus, OH

Hematologic Oncology, Sarcoma, Clinical Informatics

Associate Professor, The Ohio State & SVP Cancer Informatics, Tempus Labs

Dr. Chen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Chen's full profile

Already have an account?

  • Office

    460 W 10th Ave
    Columbus, OH 43210
    Phone+1 614-293-6529
    Fax+1 614-293-9469

Education & Training

  • Rutgers New Jersey Medical School
    Rutgers New Jersey Medical SchoolClass of 2005

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2012 - 2025
  • IL State Medical License
    IL State Medical License 2008 - 2014
  • DC State Medical License
    DC State Medical License 2005 - 2008
  • VA State Medical License
    VA State Medical License 2005 - 2008
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Journal Articles

  • The Omics Revolution Continues: The Maturation of High-Throughput Biological Data Sources  
    James L Chen, John L Hays, Yearbook of Medical Informatics
  • Loss of TXNIP Enhances Peritoneal Metastasis and Can Be Abrogated by Dual TORC1/2 Inhibition  
    David Cohen, James L Chen, John L Hays, Oncotarget

Abstracts/Posters

  • An All Antibody Approach for Conditioning Bone Marrow for Hematopoietic Stem Cell Transplantation with Anti-cKIT and Anti-CD47 in Non-Human Primates
    James Y Chen, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

  • Deriving real-world oral antineoplastic treatment endpoints: A comparison of automated data extraction versus manual chart abstraction. 
    2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

  • Tempus Announces Three Abstracts Accepted for Presentation at the European Society for Medical Oncology
    Tempus Announces Three Abstracts Accepted for Presentation at the European Society for Medical OncologySeptember 12th, 2022
  • Tempus Announces 14 Abstracts Accepted for Presentation at the American Society of Clinical Oncology Annual Meeting 2022
    Tempus Announces 14 Abstracts Accepted for Presentation at the American Society of Clinical Oncology Annual Meeting 2022June 6th, 2022
  • Inhibition of Histone Deacetylase 2 Reduces MDM2 Expression and Reduces Tumor Growth in Dedifferentiated Liposarcoma
    Inhibition of Histone Deacetylase 2 Reduces MDM2 Expression and Reduces Tumor Growth in Dedifferentiated LiposarcomaOctober 4th, 2019

Professional Memberships